FDA Adverse Event Malfunction Summary report: N

REAGENT RED BLOOD CELLS 0.8% RESOLVE PANEL C

MDR report key: 6169903 · Received December 13, 2016

Report

Report Number
2250051-2016-00107
Event Type
Malfunction
Date Received
December 13, 2016
Date of Event
November 21, 2016
Report Date
December 13, 2016
Manufacturer
ORTHO CLINICAL DIAGNOSTICS
Product Code
KSZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

ORTHO PERFORMED BATCH REVIEW, COMPLAINT REVIEW BY LOT. RETAIN HAD EXPIRED PRIOR TO CUSTOMER REPORT. ALL RESULTS WERE SATISFACTORY. SAMPLE WAS NOT RETURNED TO ORTHO FOR FURTHER INVESTIGATION. (B)(4).

Description of Event or Problem · 1

CUSTOMER REPORTED A FALSE NEGATIVE REACTION FOR ONE PATIENT THAT LATER WAS ID WITH ANTI-JSA IN THEIR PLASMA. PATIENT WAS TESTED AT FACILITY ON (B)(6) 2016 WITH 2+ POSITIVE REACTION NOTED WITH 0.8% SCREENING. INFORMATION ON ANTIGRAM INDICATED DONOR # WAS NOT TESTED FOR JSA ANTIGEN. USING VRC226 ONLY CELL # 6 REACTED 2+. CUSTOMER PERFORMED ADDITIONAL TESTING USING IMMUCOR CELLS AND FOUND CELLS THAT WERE JSA POSITIVE REACTING WITH SAMPLE. CUSTOMER THEN RETEST CELL# 6 FROM VRC226 ( UNTREATED) WITH "KNOWN ANTI-JSA ANTISERA", AND STATED DONOR IS REACTING 2+. CUSTOMER WAS ABLE TO CONFIRMED ANTIBODY ( ANTI-JSA). ISSUE STARTED ON: (B)(6) 2016, REPORTED 11-22-16. INCUBATION TIME (FOR MANUAL TEST ONLY): 15 MINUTES. DAILY QC PERFORMED AND FOUND TO BE ACCEPTABLE. TRANSFUSION HISTORY: NOT PROVIDED ON PATIENT. SAMPLE TYPE: EDTA PLASMA. CARDS /CASSETTES/RBC STORAGE CONDITION TEMPERATURE: PER IFU VISUAL APPEARANCE BEFORE USE: ALL REAGENTS HAD A NORMAL APPEARANCE PRIOR TO USE. ORTHO CARE DISCUSSED WITH CUSTOMER THAT DUE TO LACK OF ORTHO ANTISERA (ANTI-JSA) WE WOULD NOT BE ABLE TO CONFIRMED THE ANTIGEN ON DONOR CELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
820236 REAGENT RED BLOOD CELLS 0.8% RESOLVE PANEL C REAGENT RED BLOOD CELLS KSZ ORTHO CLINICAL DIAGNOSTICS VRC226

Patients

Seq Age Sex Outcome Treatment
1